| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | BIOTECHNOLOGY VALUE FUND L P | Kura Oncology, Inc. | 3,801,949 | 5.1% | EDGAR |
| SC 13G/A | 2024-02-14 | EcoR1 Capital, LLC | Kura Oncology, Inc. | 7,598,797 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | Kura Oncology, Inc. | 7,472,343 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Kura Oncology, Inc. | 4,037,691 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-12 | Flynn James E | Kura Oncology, Inc. | 5,312,733 | 7.2% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | Kura Oncology, Inc. | 7,315,647 | 9.8% | EDGAR |
| SC 13G/A | 2024-01-23 | STATE STREET CORP | Kura Oncology, Inc. | - | 3.9% | EDGAR |
| SC 13G | 2023-09-21 | Flynn James E | Kura Oncology, Inc. | 4,374,044 | 5.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Avoro Capital Advisors LLC | Kura Oncology, Inc. | 3,105,000 | 4.5% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | Kura Oncology, Inc. | 2,010,123 | 3.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Kura Oncology, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | Kura Oncology, Inc. | 6,376,815 | 9.3% | EDGAR |
| SC 13G/A | 2023-02-10 | EcoR1 Capital, LLC | Kura Oncology, Inc. | 6,638,371 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-10 | Flynn James E | Kura Oncology, Inc. | 2,383,000 | 3.6% | EDGAR |
| SC 13G | 2023-02-09 | VANGUARD GROUP INC | Kura Oncology, Inc. | 3,405,169 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-03 | STATE STREET CORP | Kura Oncology, Inc. | - | 6.6% | EDGAR |
| SC 13G/A | 2023-01-31 | BlackRock Inc. | Kura Oncology, Inc. | 5,162,836 | 7.6% | EDGAR |
| SC 13G | 2022-12-05 | BIOTECHNOLOGY VALUE FUND L P | Kura Oncology, Inc. | 1,825,402 | 2.7% | EDGAR |
| SC 13G/A | 2022-03-10 | FMR LLC | Kura Oncology, Inc. | 241,463 | 0.4% | EDGAR |
| SC 13G/A | 2022-02-11 | SUVRETTA CAPITAL MANAGEMENT, LLC | Kura Oncology, Inc. | 3,572,419 | 5.4% | EDGAR |